Evidence map›Paper›PMID 17982067›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2007

Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity.

Zoran V Popovic, Roger Sandhoff, Tjeerd P Sijmonsma, Sylvia Kaden, Richard Jennemann, Eva Kiss, Edgar Tone, Frank Autschbach, Nick Platt, Ernst Malle and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. From gene identifications to therapeutic targets for asthma: Focus on great potentials ofChinese medical journal pulmonary and critical care medicine · 2023
    Review
  4. Article
  5. Article
  6. Role of macrophages in progression of colorectal cancer: a contrast with the traditional paradigm.International journal of clinical and experimental pathology · 2022
    Article
  7. Article
  8. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Role of mTOR Signaling in Tumor Microenvironment: An Overview.International journal of molecular sciences · 2018
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Recent advances in colorectal cancer research: the microenvironment impact.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2011
    Article
  20. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Zoran V PopovicDepartment of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany. Z.Popovic@dkfz.de
Roger Sandhoff
Tjeerd P Sijmonsma
Sylvia Kaden
Richard Jennemann
Eva Kiss
Edgar Tone
Frank Autschbach
Nick Platt
Ernst Malle
Hermann-Josef Gröne
Heidelberg University · DEGerman Cancer Research Center · DEMedical University of Graz · ATUniversity of Southampton · GB

Funding

Austrian Science Fund FWF P 19074
6 · The paper itself

Abstract

Sulfoglycolipids are present on the surface of a variety of cells. The sulfatide SM4s is increased in lung, renal, and colon cancer and is associated with an adverse prognosis, possibly due to a low immunoreactivity of the tumor. As macrophages significantly contribute to the inflammatory infiltrate in malignancies, we postulated that SM4s may modulate macrophage function. We have investigated the effect of SM4s on the uptake of apoptotic tumor cells, macrophage cytokine profile, and receptor expression. Using flow cytometry and microscopic analyses, we found that coating apoptotic murine carcinoma cells from the colon and kidney with SM4s promoted their phagocytosis by murine macrophages up to 3-fold ex vivo and in vivo. This increased capacity was specifically inhibited by preincubation of macrophages with oxidized or acetylated low density lipoprotein and maleylated albumin, indicating involvement of scavenger receptors in this interaction. The uptake of SM4s-coated apoptotic cells significantly enhanced macrophage production of TGF-beta1, expression of P-selectin, and secretion of IL-6. These data suggest that SM4s within tumors may promote apoptotic cell removal and alter the phenotype of tumor-associated macrophages.

Indexed as

AlbuminsAnimalsApoptosisBiomarkers, TumorCell Line, TumorColonic NeoplasmsGlycolipidsHumansInflammationInterleukin-6Kidney NeoplasmsLipoproteins, LDLLung NeoplasmsMacrophagesMiceMice, Inbred BALB CAlbuminsBiomarkers, TumorGlycolipidsIL6 protein, humanInterleukin-6Lipoproteins, LDLMonokinesoxidized low density lipoproteinP-SelectinReceptors, ScavengersulfoglycolipidsTransforming Growth Factor beta1

Identifiers

PMID17982067
PMCPMC4861212
OpenAlexW1707440303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.